Nalaganje...
Sofosbuvir: a novel oral agent for chronic hepatitis C
Major changes have emerged during the last few years in the therapy of patients with chronic hepatitis C (CHC). Several direct acting antiviral agents (DAAs) have been developed showing potent activity against hepatitis C virus (HCV) and incrementally improving the rates of sustained virological res...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hellenic Society of Gastroenterology
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4188929/ https://ncbi.nlm.nih.gov/pubmed/25332066 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|